
==== Front
Adv TherAdv TherAdvances in Therapy0741-238X1865-8652Springer Healthcare Heidelberg 10310.1007/s12325-014-0103-2ErratumErratum to: OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology Ginsberg David ginsberg@ccnt.usc.edu Cruz Francisco Herschorn Sender Gousse Angelo Keppenne Véronique Aliotta Philip Sievert Karl-Dietrich Brin Mitchell F. Jenkins Brenda Thompson Catherine Lam Wayne Heesakkers John Haag-Molkenteller Cornelia  Department of Urology, University of Southern California Institute of Urology, 1441 Eastlake Avenue, NOR 7416, Los Angeles, CA 90033-9178 USA  Faculty of Medicine do Porto, Hospital São João, IBMC, Porto, Portugal  University of Toronto, Toronto, Canada  Memorial Hospital Miramar, Miramar, FL USA  Université de Liège, Liège, Belgium  Western New York Urology Associates, Cheektowaga, NY USA  University of Tübingen, Tübingen, Germany  Allergan, Inc., Irvine, CA USA  Department of Neurology, University of California, Irvine, CA USA  Allergan Ltd, Marlow, Buckinghamshire, UK  Radboud Universiteit, Nijmegen, The Netherlands 13 2 2014 2014 31 2 242 242 © Springer Healthcare 2014issue-copyright-statement© Springer Healthcare 2014
==== Body
Erratum to: Adv Ther (2013) 30:819–833 DOI 10.1007/s12325-013-0054-z
The authors would like to make the following correction to the above mentioned article. The title should be changed from “OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology” to “OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology”.

The online version of the original article can be found under doi:10.1007/s12325-013-0054-z.
